skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan

Journal Article · · Proc. Natl. Acad. Sci. U.S.A.; (United States)

The structure of the glycosaminoglycan chain of a heparan sulfate proteoglycan isolated from the conditioned medium of an endothelial cell line has been analyzed by using various degradative enzymes (heparitinase I, heparitinase II, heparinase, glycuronidase, sulfatases) from Flavobacterium heparinum. (/sup 35/S)sulfuric acid and/or (/sup 3/H) glucosamine ucre used in preparing heparan sulfate proteoglycan. This proteoglycan inhibits the thromboplastin-activated pathway of coagulation; as a consequence, the catalytic conversion of prothrombin to thrombin is arrested. Heparitinase I, an enzyme with specificity restricted to the heparan sulfate portion of the polysaccharide, releases fragments with the electrophoretic mobility and the structure of heparin. Conversely, as assessment of the size and distribution of the heparan sulfate regions has been provided by the use of heparinase, which, by degrading the heparin sections of the chain, releases two segments that exhibit the structure of heparan sulfate. One of these segments is attached to the protein core. On the basis of these findings, the heparan sulfate chain can be defined as a copolymer containing heparin regions in its structure. The combined use of these enzymes has made it possible to establish the disaccharide sequence of parts of the glycosaminoglycan moiety of this proteoglycan.

Research Organization:
W. Alton Jones Cell Science Center, Lake Placid, NY
OSTI ID:
5303064
Journal Information:
Proc. Natl. Acad. Sci. U.S.A.; (United States), Vol. 84:11
Country of Publication:
United States
Language:
English